Shortages of many essential drugs amid the COVID-19 crisis reveal serious vulnerabilities in the systems for supplying and distributing pharmaceuticals in the United States, according to a new report led by researchers at the Johns Hopkins Bloomberg School of Public Health. In the report, “The Pandemic and the Supply Chain,” the researchers identify multiple problems
Shortages of many essential drugs amid the COVID-19 crisis reveal serious vulnerabilities in the systems for supplying and distributing pharmaceuticals in the United States, according to a new report led by researchers at the Johns Hopkins Bloomberg School of Public Health. In the report, “The Pandemic and the Supply Chain,” the researchers identify multiple problems
Kinks in quickly established new production and distribution supply chains are a major reason why COVID-19 vaccines approved for use in the United States have been sluggish finding their way into people’s arms, says an expert in logistics and supply chains at The University of Alabama in Huntsville (UAH), a part of the University of
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok